Powered by Smartsupp

Strattera

$100.00$380.00

Buy Strattera Online Without Prescription. Strattera influences brain and nerve chemicals that lead to hyperactivity and impulse control. Attention Deficit Hyperactivity Disorder is treated with Strattera (ADHD). Strattera may be used for other applications not covered in this pharmaceutical guide.

Atomoxetine, sold under the brand name Strattera, among others, is a medication used to treat attention deficit hyperactivity disorder. It may be used alone or along with psychostimulants. It is also used as a cognitive enhancer to improve alertness, attention, and memory. Atomoxetine For Sale Online.
  • Molar mass: 255.36 g/mol
  • Other names: (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine
  • Metabolism: Liver, via CYP2D6
  • Protein binding: 98%
  • AHFS/Drugs.com: Monograph
  • ATC code: N06BA09 (WHO)
  • Bioavailability: 63 to 94%
SKU: N/A Category:

Description

Buy Strattera Online Without Prescription

Buy Strattera Online Without Prescription. Strattera influences brain and nerve chemicals that lead to hyperactivity and impulse control. Attention Deficit Hyperactivity Disorder is treated with Strattera (ADHD). Strattera may be used for other applications not covered in this pharmaceutical guide.

Atomoxetine, sold under the brand name Strattera, among others, is a medication used to treat attention deficit hyperactivity disorder. It may be used alone or along with psychostimulants. It is also used as a cognitive enhancer to improve alertness, attention, and memory. Atomoxetine For Sale Online.
  • Molar mass: 255.36 g/mol
  • Other names: (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine
  • Metabolism: Liver, via CYP2D6
  • Protein binding: 98%
  • AHFS/Drugs.com: Monograph
  • ATC code: N06BA09 (WHO)
  • Bioavailability: 63 to 94%

Warnings

If you have narrow-angle glaucoma, an adrenal gland tumor, heart disease or coronary artery disease, or moderate to severe high blood pressure, you should not use Strattera. If you have taken an MAO inhibitor within the last 14 days, including isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others, do not use Strattera.

Psychosis (strange thoughts or behavior) may develop or worsen while using Strattera, particularly if you have a history of depression, mental illness, or bipolar disorder.

Strattera has been linked to stroke, heart attack, and sudden death in patients with hypertension, heart disease, or a heart defect. Some adolescents report suicidal thoughts when they initially begin taking this medication or anytime the dosage is altered. Maintain vigilance for changes in your mood or symptoms, particularly if you have ever entertained suicide ideas.

Before taking this medicine

Do not use Strattera if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others. You should not use this medicine if you are allergic to atomoxetine, or if you have:

  • severe heart or blood vessel problems;
  • narrow-angle glaucoma; or
  • pheochromocytoma (tumor of the adrenal gland).

Strattera has caused stroke, heart attack, and sudden death in certain people. Tell your doctor if you have:

  • heart problems or a congenital heart defect;
  • high blood pressure; or
  • a family history of heart disease or sudden death.

To make sure this medicine is safe for you, tell your doctor if you or anyone in your family has ever had:

  • depression, mental illness, bipolar disorder, psychosis;
  • suicidal thoughts or actions;
  • low blood pressure; or
  • liver disease.

Some adolescents report suicidal thoughts while initially using Strattera or anytime the dosage is altered. Your doctor must monitor your development at frequent intervals. Additionally, your family and other caregivers should be aware of any changes in your mood or symptoms.

It is unknown if this medication may damage a fetus. Before using Strattera, inform your doctor if you are pregnant or intend to get pregnant. If you are pregnant, your name may be entered into a pregnancy registry in order to monitor the effects of atomoxetine on the fetus. Strattera may not be safe to use when breastfeeding. Ask your doctor about any potential risks, since Strattera is not FDA-approved for use in children under 6 years of age.

How should I take Strattera?

  • Take Strattera exactly as prescribed by your doctor. Follow all directions on your prescription label. Your doctor may occasionally change your dose. Do not use this medicine in larger or smaller amounts or for longer than recommended.
  • Take the medicine at the same time each day, with a full glass of water.
  • Strattera is usually taken once daily in the morning, or two times per day in the morning and late afternoon. Follow your doctor’s instructions.
  • You may take this medicine with or without food.
  • Do not crush, chew, break, or open a Strattera capsule. Swallow the capsule whole. Tell your doctor if you have trouble swallowing the capsules.
  • Use Strattera regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.
  • Do not use a capsule that has been opened or accidentally broken. The medicine from inside the capsule can be dangerous if it gets in your eyes. If this occurs, rinse your eyes with water. Ask your doctor or pharmacist how to safely handle and dispose of a broken capsule.
  • While taking Strattera, your doctor will need to check your progress at regular visits. Your heart rate, blood pressure, height and weight may also need to be checked often.
  • Store at room temperature away from moisture and heat.

Dosing information

Usual Adult Dose for Attention Deficit Disorder:

-Initial Dose: 40 mg/day orally.
-Maintenance Dose: Increase dose to 80 mg/day orally after a minimum of 3 days at the initial dose.
-Maximum Dose: After 2 to 4 additional weeks, the dose may be increased up to 100 mg/day in patients who have not achieved an optimal response.

Comments: Take dose once a day in the morning OR as evenly divided doses in the morning and late afternoon/early evening.
Use: Treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Usual Pediatric Dose for Attention Deficit Disorder:

70 kg or Less:
-Initial Dose: 0.5 mg/kg/day orally.
-Maintenance dose: Increase dose to 1.2 mg/kg/day after a minimum of 3 days at the initial dose.
-Maximum dose: 1.4 mg/kg/day or 100 mg/day, whichever is less.

Over 70 kg:
-Initial Dose: 40 mg/day orally.
-Maintenance dose: Increase dose to 80 mg/day after a minimum of 3 days at the initial dose.
-Maximum dose: After 2 to 4 additional weeks, the dose may be increased up to 100 mg/day in patients who have not achieved an optimal response.
Comments: Take dose once a day in the morning OR as evenly divided doses in the morning and late afternoon/early evening.
Use: Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients age 6 and older.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.  Overdose symptoms may include drowsiness, dizziness, stomach problems, tremors, or unusual behavior.

What to avoid

Avoid using or handling an open or broken capsule. If the powder from inside the capsule gets in your eyes, rinse them with water right away and call your doctor. Avoid driving or hazardous activity until you know how Strattera will affect you. Your reactions could be impaired.

Strattera side effects

Obtain immediate medical attention if you have the following symptoms of an allergic response to Strattera: hives; difficulty breathing; and swelling of the face, lips, tongue, or neck. Notify your doctor of any new or worsening symptoms, such as anxiety, panic attacks, difficulty sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), sad, or have suicidal or self-harming ideas. Strattera may influence a child’s development. Inform your doctor if your child’s growth is not normal while taking this medication. Contact your doctor immediately if you have:

  • signs of heart problems – chest pain, trouble breathing, feeling like you might pass out;
  • signs of psychosis – hallucinations (seeing or hearing things that are not real), new behavior problems, aggression, hostility, paranoia;
  • liver problems – stomach pain (upper right side), itching, flu-like symptoms, dark urine, jaundice (yellowing of the skin or eyes);
  • painful or difficult urination; or
  • erection is painful or lasts longer than 4 hours (this is a rare side effect).

Common Strattera side effects may include:

  • nausea, vomiting, upset stomach, constipation;
  • dry mouth, loss of appetite;
  • mood changes, insomnia, feeling tired;
  • dizziness;
  • increased sweating;
  • urination problems; or
  • impotence, trouble having an erection.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Strattera?

Tell your doctor about all your current medicines and any you start or stop using, especially:

  • an antidepressant;
  • asthma medication;
  • blood pressure medicine; or
  • a cold or allergy medicine that contains a decongestant such as pseudoephedrine or phenylephrine.

This list is not complete. Other drugs may interact with atomoxetine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Additional information

Quantity

25 mg/ 30 Pills, 25 mg/ 90 Pills, 25 mg/ 120 Pills, 40 mg/ 30 Pills, 40 mg/ 90 Pills, 40 mg/ 120 Pills

Reviews

There are no reviews yet.

Be the first to review “Strattera”

Your email address will not be published. Required fields are marked *